Related references
Note: Only part of the references are listed.An interconnected hierarchical model of cell death regulation by the BCL-2 family
Hui-Chen Chen et al.
NATURE CELL BIOLOGY (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J. D. Leverson et al.
CELL DEATH & DISEASE (2015)
Mutations in USP9X Are Associated with X-Linked Intellectual Disability and Disrupt Neuronal Cell Migration and Growth
Claire C. Homan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
A. C. Murphy et al.
APOPTOSIS (2014)
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis
B. Wang et al.
CELL DEATH AND DIFFERENTIATION (2014)
Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
Xingnan Zheng et al.
GENES & DEVELOPMENT (2014)
PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD
Fresia Pareja et al.
MOLECULAR CANCER RESEARCH (2014)
Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma
Catherine Gratas et al.
ONCOTARGET (2014)
Dihydroartemisinin is a hypoxia-active anti-cancer drug in colorectal carcinoma cells
Teona Ontikatze et al.
FRONTIERS IN ONCOLOGY (2014)
The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells
Jesse L. Cox et al.
PLOS ONE (2013)
ABT-263 Enhances Sensitivity to Metformin and 2-Deoxyglucose in Pediatric Glioma by Promoting Apoptotic Cell Death
Jane Levesley et al.
PLOS ONE (2013)
Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGFβ-Mediated Axonogenesis
Shane Stegeman et al.
PLOS ONE (2013)
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
Bryant England et al.
TUMOR BIOLOGY (2013)
p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737
Katrin E. Tagscherer et al.
APOPTOSIS (2012)
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Chander Peddaboina et al.
BMC CANCER (2012)
Deubiquitinase USP9x Confers Radioresistance through Stabilization of Mcl-1
Donatella Trivigno et al.
NEOPLASIA (2012)
c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells
John C. Allen et al.
BLOOD (2011)
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
P. N. Kelly et al.
CELL DEATH AND DIFFERENTIATION (2011)
Synergistic Antitumor Activity of Gemcitabine and ABT-737 In Vitro and In Vivo through Disrupting the Interaction of USP9X and Mcl-1
Chong Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1
S. Huber et al.
LEUKEMIA (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
Carlos A. Fedrigo et al.
RADIATION ONCOLOGY (2011)
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Martin Schwickart et al.
NATURE (2010)
GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
Aaron C. Spalding
NEOPLASIA (2010)
Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling
Bilal A. Azakir et al.
CELLULAR SIGNALLING (2009)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization
Qingqing Ding et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X
Rania Mouchantaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis
Q Zhong et al.
CELL (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Nora, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
E Oda et al.
SCIENCE (2000)
Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis
C Belka et al.
ONCOGENE (2000)
Share Paper
